In conjunction with a recent drug development program,
we became interested in the furopyridinone ring system, a
key structural subunit prevalent in numerous natural products
and structural analogues associated with interesting biological
activities.15 Pursuant to our longstanding interest in Pd-
catalyzed cyclization processes, we have recently reported
the construction of 2,3-disubstituted furo[2,3-b]pyridin-
4(1H)-ones from 3-alkynylpyridin-2(1H)-ones (3-alkynyl-
2-pyridones) and aryl halides.16 As a complement to this
chemistry, we have now investigated the reactivity of the
alkynylpyridones toward iodonium reagents.
alkyl group from the remote alkyl ether on the 2-pyridone
nucleus to afford the desired 3-iodofuro[2,3-b]pyridin-4(1H)-
ones 3 (Scheme 1, eq 2). The alternative heteroannulative
pathway that would lead to the regioisomeric furo[3,2-c]-
pyridin-2(1H)-ones (4) via preferential attack of the triple
bond by the alkoxy group17 could also be expected (Scheme
1, eq 3). The iodocyclization precursors 1 were prepared from
the corresponding 3-iodo-2-pyridones via Pd-catalyzed cross-
coupling reaction with terminal alkynes. Gratifyingly, pre-
liminary experiments conducted with 2-pyridone 1a as a
model substrate have shown that iodine could indeed promote
the expected iodocyclization, whereas other iodonium sources
(ICl, NIS) proved rather inefficient. The reaction proceeded
cleanly at room temperature in CH2Cl2 in the presence of 2
equiv of I2 to afford within 5 h the corresponding pyridinium
triiodide salt 2a exclusively, in 79% isolated yield (eq 4).
Iodonium-promoted cyclizations often require a removable
functional group on the nucleophile, which implies a stepwise
electrophilic addition/dealkylation sequence involving cat-
ionic intermediates (Scheme 1, eq 1). Recent methods have
Scheme 1. Heteroannulative Strategies toward Fused
Heterocycles
The generality of the cyclization process was then explored
with other N,O-dialkylated pyridones. The results sum-
marized in Table 1 demonstrate that I2 was efficient in most
cases and a variety of annulated 3-iodofurans were obtained
under the standard conditions. Best results have been
achieved with aryl-substituted alkynes 1a-e (Table 1, entries
1-5), which provided the corresponding 2-aryl-3-iodofurans
in good yields. Alkyl-substituted alkyne 1f participated less
efficiently in the cyclization process (Table 1, entry 6),
whereas acetylene 1g bearing a SiMe3 group led to a complex
mixture of products (Table 1, entry 7). Finally, to explore
the scope and generality of the reaction, we further examined
the cyclization of the benzo-homologated substrate 1h. If
successful, this would open access to analogous derivatives
of the linearly fused furoquinoline alkaloids, of which some
important members are substituted at the nitrogen atom,
either in the form of 4-methoxyquinolinium methosalts or
N-alkylated quinolin-4-ones.18 To our satisfaction, 1h af-
forded the desired furoquinolinium triiodide 2h under identi-
cal reaction conditions, albeit in a moderate 56% isolated
yield (Table 1, entry 8).
been mainly focused on the cyclization of readily available
ortho-functionalized aryl (or heteroaryl) acetylenes. Notably,
o-benzyloxyalkynylpyridines have been shown to yield
3-iodofuro[2,3-b]pyridines upon exposure to iodine in basic
medium.4 In contrast, and in analogy to our previous work,
we anticipated that 4-alkoxy-1-methyl-2-pyridones (1) would
generate pyridinium salts 2 as intermediates and that,
hopefully, the counterion would subsequently displace the
Having examined the scope of the iodocyclization process,
we sought an effective method to convert the pyridinium
and quinolinium triiodide salts into the corresponding pyri-
dinones and quinolinone, respectively.19 Various methods
have been reported to effect the O-dealkylation of 4-alkoxy-
(10) (a) Barluenga, J.; Va´zquez-Villa, H.; Ballesteros, A.; Gonza´lez, J.
M. J. Am. Chem. Soc. 2003, 125, 9028. (b) Yue, D.; Della Ca`, N.; Larock
R. C. Org. Lett. 2004, 6, 1581.
(11) (a) Yao, T.; Larock, R. C. J. Org. Chem. 2003, 68, 5936. (b) Rossi,
R.; Carpita, A.; Bellina, F.; Stabile, P.; Mannina, L. Tetrahedron 2003, 59,
2067.
(12) Peng, A.-Y.; Ding, Y.-X. Org. Lett. 2004, 6, 1119.
(13) Yao, T.; Yue, D.; Larock, R. C. J. Org. Chem. 2005, 70, 9985.
(14) For other recent examples of iodonium-promoted heterocyclizations
of acetylenic compounds, see: (a) Sniady, A.; Wheeler, K. A.; Dembinski,
R. Org. Lett. 2005, 7, 1769. (b) Liu, Y.; Song, F.; Cong, L. J. Org. Chem.
2005, 70, 6999. (c) Yao, T.; Zhang, X.; Larock, R. C. J. Org. Chem. 2005,
70, 7679. (d) Liu, Y.; Zhou, S. Org. Lett. 2005, 7, 4609. (e) Waldo, J. P.;
Larock R. C. Org. Lett. 2005, 7, 5203.
(17) An example of such an outcome, albeit not involving activation by
iodonium species, has been reported: Gaston, J. L.; Greer, R. J.; Grundon,
M. F. J. Chem. Res., Miniprint 1985, 1873.
(18) (a) Pirrung, M. C.; Blume, F. J. Org. Chem. 1999, 64, 3642 and
references therein. (b) Wu, T.-S.; Li, C.-Y.; Leu, Y.-L.; Hu, C.-Q.
Phytochemistry 1999, 50, 509. (c) Chang, G.-J.; Wu, M.-H.; Chen, W.-P.;
Kuo, S.-C.; Su, M.-J. Drug DeV. Res. 2000, 50, 170. (d) Boyd, D. R.;
Sharma, N. D.; Barr, S. A.; Carroll, J. G.; Mackerracher, D.; Malone, J. F.
J. Chem. Soc., Perkin Trans. 1 2000, 3397. (e) Bar, G.; Parsons, A. F.;
Thomas, C. B. Tetrahedron 2001, 57, 4719.
(15) Michael, J. P. Nat. Prod. Rep. 2005, 22, 627 and previous annual
reports.
(16) Bossharth, E.; Desbordes, P.; Monteiro, N.; Balme, G. Org. Lett.
2003, 5, 2441.
1114
Org. Lett., Vol. 8, No. 6, 2006